Analysis of clinical effects on 211 cases with middle and late stage lung cancer

Xin Yu-ling

doi:10.1007/BF02940689

Your Location：

Home >

Browse articles >

Analysis of clinical effects on 211 cases with middle and late stage lung cancer

Updated：2021-08-27

- Analysis of clinical effects on 211 cases with middle and late stage lung cancer
- Chinese Journal of Integrative Medicine Vol. 1, Issue 4, Pages: 249-254(1995)
- Affiliations：
  
  Japan Friendship Hospital,Beijing,China
- Author bio：
- Funds：
- DOI：10.1007/BF02940689
  CLC：
- Published：1995，
Scan for full text
Xin, Yl. Analysis of clinical effects on 211 cases with middle and late stage lung cancer., CJIM 1, 249–254 (1995). https://doi.org/10.1007/BF02940689

Xin Yu-ling. Analysis of clinical effects on 211 cases with middle and late stage lung cancer. [J]. Chinese Journal of Integrative Medicine 1(4):249-254(1995)
Xin, Yl. Analysis of clinical effects on 211 cases with middle and late stage lung cancer., CJIM 1, 249–254 (1995). https://doi.org/10.1007/BF02940689 DOI：

Xin Yu-ling. Analysis of clinical effects on 211 cases with middle and late stage lung cancer. [J]. Chinese Journal of Integrative Medicine 1(4):249-254(1995) DOI： 10.1007/BF02940689.

摘要

The clinical efficacy obtained from 211 cases of middle and late stage lung cancer treated by electrochemical therapy (ECT) were summarized. The responses are divided into CR

PD according to the international standard of four grades. The short term effectiveness within one year was: CR (29.4%) and PR (40.3%) were assessed as the total effective rate being 69.7%

NR (13.3%) and PD (17.1%) were assessed as ineffective. The efficacy of traditional Chinese medicine (TCM) group was 54.3%; that of ECT group was 70.4%; while that of TCM combined with Western medicine group (ECT+TCM) was 84.3%. The efficacy of ECT+TCM group was superior to the formerr two groups (P<0.05). The 5 years long term effectiveness of ECT group was 31.0%

TCM group 15.7%

ECT+TCM group 40.0%. Clinical analysis showed that the effect of ECT+TCM group was the best.

Abstract

The clinical efficacy obtained from 211 cases of middle and late stage lung cancer treated by electrochemical therapy (ECT) were summarized. The responses are divided into CR

PD according to the international standard of four grades. The short term effectiveness within one year was: CR (29.4%) and PR (40.3%) were assessed as the total effective rate being 69.7%

TCM group 15.7%

ECT+TCM group 40.0%. Clinical analysis showed that the effect of ECT+TCM group was the best.

关键词

lung cancerelectrochemical therapyTraditional Chinese Medicine

Keywords

lung cancerelectrochemical therapyTraditional Chinese Medicine

references

Nordenstrom BEW. Biologically Closed Electric Circuits. AJR 1985; 145–147.

FULL TEXT LINK

More>

Views

752

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Delisheng Injection (得力生注射液), a Chinese medicinal compound, enhanced the effect of cis-platinum on lung carcinoma cell line PGCL3

Syndrome pattern and its application in parallel randomized controlled trials

Integration of Chinese medicine and Western medicine in clinical practice (Patient Care): Past, present, and a proposed model for the future

The Western model of integrative oncology — the contribution of Chinese medicine

Traditional Chinese medicine and the positive correlation with homeostatic evolution of human being: Based on medical perspective

Related Author

No data

Related Institution

Department of Respiratory, the Second Affiliated Hospital, College of Medicine of Xi’an Jiaotong University

Department of Pharmacy, the Fourth People’s, Hospital of Ji’nan City, Ji’nan

Department of Respiratory, Zibo Central Hospital

Division of Clinical Medicine, School of Korean Medicine, Pusan National University, Yangsan, Republic of Korea

Department of Korean Medicine, School of Korean Medicine, Pusan National University, Yangsan, Republic of Korea

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰